Gary D Glick

USPTO Granted Patents = 66 (Patent Applications = 36)

CIPO Patents = 6 (Patent Applications = 3)

EPO Patents = 23 (Patent Applications = 34)

Average Co-Inventor Count = 1.9

ph-index = 12

Forward Citations = 437(Granted Patents)

Forward Citations (Not Self Cited) = 193(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

28 out of 3,381

University of Michigan

Innate Tumor Immunity, Inc.

Novartis Inflammasome Research, Inc.

Years Active: 2000-2025

Loading Chart...

Areas of Expertise:

NLRP3 Modulators

Inflammatory Response

Cyclic Dinucleotides

STING Activity

Benzodiazepine Compounds

Therapeutic Applications

Adoptive Cellular Therapy

Pro-Apoptotic Agents

RORγ Inhibition

Cancer Treatment

Skin Conditions

Cell Proliferation Inhibition

66 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12351580 - NLRP3 modulators (2025-07-08),

2. 12084424 - Compounds and compositions for treating conditions associated with NLRP activity (2024-09-10),

3. 11827632 - NLRP3 modulators (2023-11-28),

4. 11793777 - Methods and compositions for treating conditions associated with an abnormal inflammatory response (2023-10-24),

5. 11760735 - Compounds and compositions for treating conditions associated with NLRP activity (2023-09-19),

6. 11744812 - Methods of treatment (2023-09-05),

7. 11724992 - Compounds and compositions for treating conditions associated with NLRP activity (2023-08-15),

8. 11618749 - Compounds and compositions for treating conditions associated with STING activity (2023-04-04),

9. 11597706 - Compounds and compositions for treating conditions associated with NLRP activity (2023-03-07),

10. 11564896 - Methods of treatment (2023-01-31),

11. 11505571 - Compounds and compositions for treating conditions associated with sting activity (2022-11-22),

12. 11447460 - Compounds and compositions for treating conditions associated with NLRP activity (2022-09-20),

13. 11370763 - Compounds and compositions for treating conditions associated with NLRP activity (2022-06-28),

14. 11339136 - Compounds and compositions for treating conditions associated with NLRP activity (2022-05-24),

15. 11203579 - Compounds and compositions for treating conditions associated with NLRP activity (2021-12-21),

Title: The Innovative Journey of Gary D Glick

Introduction: Gary D Glick, a pioneering inventor hailing from Ann Arbor, MI, has made significant contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: Gary D Glick holds several patents in the areas of drug discovery, molecular biology, and immunotherapy, showcasing his continuous innovation and dedication to advancing healthcare technologies.

Career Highlights: With a distinguished career spanning several decades, Gary D Glick has served in key research and leadership roles in renowned biotech companies and academic institutions. His groundbreaking work has led to the development of novel therapies for various diseases.

Collaborations: Throughout his career, Gary D Glick has collaborated with leading scientists, researchers, and industry experts to drive forward cutting-edge projects and bring innovative solutions to the market. His collaborative spirit has been instrumental in the success of many ventures.

Conclusion: Gary D Glick's passion for innovation and his relentless pursuit of scientific excellence have established him as a prominent figure in the world of biotechnology. His work continues to inspire future generations of inventors and researchers in the quest for groundbreaking discoveries.

This text is generated by artificial intelligence and may not be accurate.